Cannabis Based Drugs Could Offer New Hope for Inflammatory Bowel Disease Patients
Treatment of The Inflammatory Bowel Disease (IBD)
Researchers investigating anecdotal evidence that cannabis relieves some of the symptoms of inflammatory bowel disease (IBD) have discovered a potential new target for cannabis-derived drugs for treatment of the disease.
This finding, published in the journal Gastroenterology today, could bring new hope for the UK's 90,000 - 180,000 sufferers of diseases like Crohn's and ulcerative colitis* with the possibility that cannabis-derived drugs may help to heal the gut lining, which is damaged during the course of disease.
Both Crohn's and ulcerative colitis - often referred to under the umbrella term of